Management of Opioid-Tolerant Patients with Acute Pain: Approaching the Challenges

被引:16
|
作者
Macintyre, Pamela E. [1 ,2 ]
Roberts, Lindy J. [3 ,4 ]
Huxtable, Christine A. [1 ,2 ]
机构
[1] Royal Adelaide Hosp, Dept Anaesthesia Pain Med & Hyperbar Med, Acute Pain Serv, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA 5000, Australia
[3] Sir Charles Gairdner Hosp, Dept Anaesthesia, Nedlands, WA 6009, Australia
[4] Sir Charles Gairdner Hosp, Dept Pain Management, Nedlands, WA 6009, Australia
关键词
TOTAL KNEE ARTHROPLASTY; CHRONIC NONCANCER PAIN; HOSPITAL TRANSITIONAL PAIN; POSTOPERATIVE PAIN; INDUCED HYPERALGESIA; RISK-FACTORS; RESPIRATORY DEPRESSION; EMERGENCY-DEPARTMENT; UNITED-STATES; USE DISORDER;
D O I
10.1007/s40265-019-01236-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For over two decades, dramatic increases in opioid prescriptions in the developed world, especially for long-term management of chronic noncancer pain, were accompanied by increases in patient harm. In recent years in the USA, opioid-related deaths rates have continued to increase despite falls in prescribing rates and deaths associated with prescription opioids. In large part, this is attributed to the growing availability of illicitly manufactured fentanyl. Increased opioid use, for medical and nonmedical reasons, has led to more opioid-tolerant patients requiring management of acute pain. The potential harms associated with long-term opioid use are now well known. What may be less well understood is that preoperative long-term opioid use is associated with increased perioperative complications including infection, readmissions, and greater healthcare utilisation and costs. Minimizing opioid use prior to surgery is a modifiable risk factor that could benefit both patient and healthcare system. Management of acute pain should include simple analgesics and adjuvants, with short-term opioid dose increases if needed and use of non-pharmacological strategies. Reported pain intensities may be high and titration of analgesia to function rather than pain scores is appropriate. Importantly, compared with opioid-naive patients, opioid-tolerant patients may be at higher risk of opioid-induced ventilatory impairment when additional opioids are administered to manage new acute pain. For some patients, perioperative care may be best coordinated by a perioperative or post-discharge service with referral to multidisciplinary pain and addiction medicine services as indicated. Carefully planned and communicated discharge prescribing, with a weaning plan for additional opioids, is essential.
引用
收藏
页码:9 / 21
页数:13
相关论文
共 50 条
  • [41] Fentanyl Pectin Nasal Spray In Breakthrough Pain in Opioid-Tolerant Adults with Cancer
    Lyseng-Williamson, Katherine A.
    CNS DRUGS, 2011, 25 (06) : 511 - 522
  • [42] Long-term safety of fentanyl sublingual spray in opioid-tolerant patients with breakthrough cancer pain
    Minkowitz, Harold
    Bull, Janet
    Brownlow, R. Charles
    Parikh, Neha
    Rauck, Richard
    SUPPORTIVE CARE IN CANCER, 2016, 24 (06) : 2669 - 2675
  • [43] Pharmacist-Led Management Improves Treatment Adherence and Quality of Life in Opioid-Tolerant Patients With Cancer Pain: A Randomized Controlled Trial
    Zheng, Xiaowei
    Ding, Haiying
    Xu, Silu
    Xie, Ruixiang
    Liu, Yuguo
    Zhai, Qing
    Fang, Luo
    Tong, Yinghui
    Sun, Jiao
    Xin, Wenxiu
    Wu, Nan
    Chen, Juan
    Shi, Wenna
    Yang, Ling
    Li, Hui
    Shao, Jingjing
    Wang, Yangkui
    Yu, Hui
    Zhang, Bo
    Du, Qiong
    Yang, Yezi
    Zhang, Xiaodan
    Duan, Cunxian
    Zhao, Qiulin
    Shi, Jing
    Huang, Jing
    Fan, Qing
    Cheng, Huawei
    Chen, Lingya
    Kong, Sisi
    Zhang, Hui
    Gong, Liyan
    Zhang, Yiping
    Song, Zhengbo
    Yang, Yang
    Zhou, Shoubing
    Huang, Chengsuo
    Lin, Jinyuan
    Wang, Chenchen
    Huang, Xianhong
    Wei, Qing
    Sun, Yancai
    Huang, Ping
    PAIN AND THERAPY, 2022, 11 (01) : 241 - 252
  • [44] Fentanyl Pectin Nasal SprayIn Breakthrough Pain in Opioid-Tolerant Adults with Cancer
    Katherine A. Lyseng-Williamson
    CNS Drugs, 2011, 25 : 511 - 522
  • [45] Pharmacist-Led Management Improves Treatment Adherence and Quality of Life in Opioid-Tolerant Patients With Cancer Pain: A Randomized Controlled Trial
    Xiaowei Zheng
    Haiying Ding
    Silu Xu
    Ruixiang Xie
    Yuguo Liu
    Qing Zhai
    Luo Fang
    Yinghui Tong
    Jiao Sun
    Wenxiu Xin
    Nan Wu
    Juan Chen
    Wenna Shi
    Ling Yang
    Hui Li
    Jingjing Shao
    Yangkui Wang
    Hui Yu
    Bo Zhang
    Qiong Du
    Yezi Yang
    Xiaodan Zhang
    Cunxian Duan
    Qiulin Zhao
    Jing Shi
    Jing Huang
    Qing Fan
    Huawei Cheng
    Lingya Chen
    Sisi Kong
    Hui Zhang
    Liyan Gong
    Yiping Zhang
    Zhengbo Song
    Yang Yang
    Shoubing Zhou
    Chengsuo Huang
    Jinyuan Lin
    Chenchen Wang
    Xianhong Huang
    Qing Wei
    Yancai Sun
    Ping Huang
    Pain and Therapy, 2022, 11 : 241 - 252
  • [46] Long-term dosing, safety, and tolerability of fentanyl buccal tablet in the management of noncancer-related breakthrough pain in opioid-tolerant patients
    Nalamachu, S. R.
    Narayana, A.
    Janka, L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (04) : 751 - 760
  • [47] Acute pain management for opioid dependent patients
    Mackenzie, J. W.
    ANAESTHESIA, 2006, 61 (09) : 907 - 908
  • [48] Acute pain management for opioid dependent patients
    Mehta, V
    Langford, RM
    ANAESTHESIA, 2006, 61 (03) : 269 - 276
  • [49] Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient
    Pan, Aileen
    Zakowski, Mark
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2017, 60 (02): : 447 - 458
  • [50] Fentanyl Buccal Tablet in Breakthrough Pain in Opioid-Tolerant Patients with CancerA Viewpoint by Donald R. Taylor
    Donald R. Taylor
    Drugs, 2006, 66 : 2394 - 2394